Avatrombopag maleate is a pharmaceutical active ingredient that acts as a thrombopoietin receptor agonist. It is used in the manufacturing of medications for conditions leading to thrombocytopenia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 677007-74-8
Avatrombopag
pharmaceutical raw material
Ethyl 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylate
research compound
Lusutrombopag
pharmaceutical raw material
Eltrombopag Amide
pharmaceutical raw material
Eltrombopag olamine
pharmaceutical raw material
Isepamicin sulfate
pharmaceutical raw material
Terconazole
pharmaceutical raw material
Šamorín
pharmaceutical raw material
(Z)-but-2-enedioic acid;1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]-2-pyridinyl]piperidine-4-carboxylic acid
MISPBGHDNZYFNM-BTJKTKAUSA-N
C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl.C(=C\C(=O)O)\C(=O)O